Implementing a new drug or technique (APA Cambridge 21. June 2013)
-
Upload
ethan-floyd -
Category
Documents
-
view
18 -
download
0
description
Transcript of Implementing a new drug or technique (APA Cambridge 21. June 2013)
Implementing a new drug or technique (APA Cambridge 21. June 2013)
Tom G. Hansen, MD, PhD, Department of Anaesthesia & Intensive Care Odense University Hospital & University of Southern DenmarkDENMARKEmail: [email protected]
Tenets of evidence based- medicine
Hierarchy of evidence
1. Systematic review of RCTs2. A single RCT3. Observational studies4. Case series and reports
Two caveats……..
• Applicability of RCTs• Quality of evidence:
large observational study vs. a small RCT
Gap between need from public health perspective and what can be afforded
Slow implementation
Clinical guidelines
The WHO definition:……systematically developed evidence
based statements which asisst providers, recipients and other stakeholders to make informed decisions about appropriate health interventions…………
Clinical guidelines: - Aims• Appropriate care• Best available evidence • Multidisciplinary groups• Systematic and transparent concensus
processes• End-user involvement• Adaptations should be re-edited• Guidance of doctors• Do not replace knowledge and skills
AGREE-II (www.agreetrust.org)23-point checklist: ….scope and purpose ….stakeholder involvement ….rigour of development ….clarity ….presentation ….applicability ….editorial independence
Guidelines - prosFacilitate EBMVariation in practiceDiscourage outdated practiceEfficiency healthcare↑ Freeing resources?Awareness on subjects↑Source of practical adviceStandardize clinical management
Guidelines - conDesigned for ”average” patients Implementation difficult:
- lack of expertise- disagreement- resources
Professional judgement Conflicts of interestExpensiveAuthorityDuplicationLack of relevant research of high qualityLegal consequences
Types of knowledge
→Explicit knowledge
→”tacit knowledge”
Requirements to guidelines• Support not constraint• Address practical questions• Short and concise• Standardized (e.g. AGREE-II)• New→ Why? Add? Divergence?• Evidense ↔ Expert opinion• Conflicts of interest• Reviewing• Revision
Who develops the guidelines?
• Local departments/hospitals• Cluster of hospitals• National• International/continental
A simple clinical question!
Expensive new evidence
The Fujii story
Retracted articles by Fujii 1991-2011
New metaanalysis withut Fujii’s studies
Carlisle’s Conclusions
……………. if data with unusual distributions
are removed from meta-analysis and articles
by Fujii et al. excluded, then the antiemetic
effects of granisetron and ramosetron are
greatly reduced; further, there is no evidence
of synergism between antiemetics and
indeed, some evidence of antagonism
between antiemetic agents…………...
Conclusions• Transfer of research possible but success
varies• Gap between recommended and received
healthcare• Causes of knowing-doing gaps unknown• Complex and context dependent process• Need for assessment of interventions• Best implementation strategy unknown• Economics?
Aesop
After all is said and done.……..more is said than done…..